Industries > Pharma > Global Medical Marijuana Market 2017-2027

Global Medical Marijuana Market 2017-2027

Chronic Pain, Arthritis, Migraine, Cancer, National Markets, Patent Analysis, Leading Companies

PUBLISHED: 22 August 2017
PAGES: 120
PRODUCT CODE: PHA0228
SUBMARKET: Therapeutic Drugs

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0228 Categories: , Tag:

The global medical marijuana market was valued at $12bn in 2016 and is projected to grow at a CAGR of 18% in the first half of the forecast period. The market is dominated by the Chronic Pain submarket which held 40% share of that market in 2016.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 120-page report you will receive 87 charts – all unavailable elsewhere.

The 120-page report provides clear detailed insight into the global medical marijuana market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Medical Marijuana Market forecasts from 2017-2027

• Revenue forecast for the medical marijuana market by Application:
• Chronic Pain
• Arthritis
• Migraine
• Cancer
• Others

Each submarket is further divided by region: North America, Europe, RoW

• This report provides individual revenue forecasts to 2027 for these regional and national medical marijuana markets:
• North America:
• USA
• Canada

• Europe:
• Belgium
• Croatia
• Finland
• France
• Italy
• Rest of Europe

• RoW:
• Israel
• Australia
• Other Countries

Global Medical Marijuana Market 2017-2027

• This report discusses the leading companies in the global medical marijuana market:
• Cara Therapeutics, Inc.
• Cannabis Sativa, Inc.
• CannaGrow Holdings, Inc.
• Aphios Corporation
• United Cannabis Corporation
• Growblox Sciences, Inc.
• GreenGro Technologies, Inc.
• GW Pharmaceutical, PLC.
• International Consolidated Companies, Inc.
• Lexaria Biosciences Corp.

• This report also listed 84 other companies involved in medical marijuana production, including their reported revenues (when available) and number of employees

• This report provides a patent analysis table for medical marijuana

• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global medical marijuana market

Visiongain’s study is intended for anyone requiring commercial analyses for the global medical marijuana market. You find data, trends and predictions.

Buy our report today Global Medical Marijuana Market 2017-2027: Chronic Pain, Arthritis, Migraine, Cancer, National Markets, Patent Analysis, Leading Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Medical Marijuana Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Medical Marijuana Market 2017-2027


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ